Home / Inspections / 1107731

FDA Inspection 1107731 — Takeda Pharmaceuticals USA, Inc.

Takeda Pharmaceuticals USA, Inc. — FEI 3002393210

The FDA completed an inspection of Takeda Pharmaceuticals USA, Inc. on October 25, 2019 in Deerfield, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 25, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Deerfield, IL (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 988237 (VAI Fri Sep 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 818340 (NAI Mon Jan 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 811093 (VAI Fri Jan 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 756349 (NAI Thu Dec 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 662088 (NAI Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources